Study examines platelet function testing for guiding antithrombotic treatment before PCI procedures

Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity (platelets resistant to antithrombotic therapy) were at an increased risk of an ischemic event at short- and long-term follow-up of up to two years, according to a new study.

Read the whole article on Science Daily

More from Science Daily